2007年发现它是一种免疫抑制剂。
该药作为一种免疫抑制剂在肝或肺移植患者中的安全性和有效性尚未得到确认。
The safety and the efficacy of sirolimus as an immunosuppressant have not been established in liver or lung transplant patients.
本文研究了不同剂量的二氯二茂钛对实验动物免疫系统的影响，提示它是一种免疫抑制剂。
This paper studies the effect of Titanocene dichlorides in different doses on the immune system in mice and indicates it is a kind of immunological suppression.
这种药物是瑞帕霉素，又被称为西罗莫司，目前被用于作为一种免疫抑制剂，有助于防止新移植肾脏发生排异。
The drug is rapamycin, also called sirolimus, and is currently used as an immunosuppressant, to help prevent rejection of a new, transplanted kidney.
雷帕霉素，另外一种抗衰老的重要健将，与白藜芦醇相比有一个非常明确的优点：雷帕霉素已经被美国食品药品管理局认可，但是是作为一种免疫抑制剂认可的。
Rapamycin, the other big candidate, has one clear advantageover resveratrol: it's already FDA approved as a drug — but as animmunosuppressant.
他克莫司是一种用于器官移植患者的重要免疫抑制剂。
Tacrolimus is an important immunosuppressive drug for organ transplantation patients.
FK506是一种新型免疫抑制剂。
谷氨酸有希望成为一种低毒有效的免疫抑制剂。
These drugs will become low toxic effective immunosuppressive agents in the future.
眼眶炎性假瘤是一种常见的眼眶疾病，病因不明，治疗方法主要包括糖皮质激素治疗、放射治疗、免疫抑制剂治疗及手术治疗等。
Orbital pseudotumor is a common orbital disease. Up to now the etiology is not clear. The therapeutic options include corticosteroids, radiation therapy, immunosuppressive agents and surgery.
他克莫司是一种器官移植患者广泛使用的免疫抑制剂，大大提高了患者的生活质量和生存率。
Tacrolimus is an widely used immunosuppressant in organ transplant patients for anti-rejection, and the quality of life and survival rate are greatly enhanced.
嗜热菌杀酵母素通过耗尽细胞的鞘脂类诱导凋亡，抑制白介素2依赖性的小鼠毒性细胞的增殖，是一种有效的免疫抑制剂。
Myriocin induces apoptosis by depletion of cellular sphingolipids, inhibits proliferation of IL-2-dependent mouse cytotoxic cells and is a potent immunosuppressant.
非对照研究表明，免疫抑制剂作为一种辅助治疗可能有益。
Anecdotal evidence suggests that immunosuppressive drugs as adjunctive therapy may be beneficial.
Ustekinumab是一种选择性的免疫抑制剂，可能有可能增加感染的危险，并重新恢复潜伏感染。
Ustekinumab is a selective immunosuppressant and may have the potential to increase the risk of infections and reactivate latent infections.
Ustekinumab是一种选择性的免疫抑制剂，可能有可能增加感染的危险，并重新恢复潜伏感染。
Ustekinumab is a selective immunosuppressant and may have the potential to increase the risk of infections and reactivate latent infections.
应用推荐